327 related articles for article (PubMed ID: 33299308)
1. Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.
Sebak AA; Gomaa IEO; ElMeshad AN; Farag MH; Breitinger U; Breitinger HG; AbdelKader MH
Int J Nanomedicine; 2020; 15():9539-9556. PubMed ID: 33299308
[TBL] [Abstract][Full Text] [Related]
2. Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective.
Sebak AA; Gomaa IEO; ElMeshad AN; Farag MH; Breitinger U; Breitinger HG; AbdelKader MH
Int J Nanomedicine; 2020; 15():8845-8862. PubMed ID: 33204091
[TBL] [Abstract][Full Text] [Related]
3. Synthetic and biological identities of polymeric nanoparticles influencing the cellular delivery: An immunological link.
Rezaei G; Daghighi SM; Raoufi M; Esfandyari-Manesh M; Rahimifard M; Mobarakeh VI; Kamalzare S; Ghahremani MH; Atyabi F; Abdollahi M; Rezaee F; Dinarvand R
J Colloid Interface Sci; 2019 Nov; 556():476-491. PubMed ID: 31473538
[TBL] [Abstract][Full Text] [Related]
4. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.
Palchetti S; Pozzi D; Capriotti AL; Barbera G; Chiozzi RZ; Digiacomo L; Peruzzi G; Caracciolo G; Laganà A
Colloids Surf B Biointerfaces; 2017 May; 153():263-271. PubMed ID: 28273493
[TBL] [Abstract][Full Text] [Related]
5. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
7. How eluents define proteomic fingerprinting of protein corona on nanoparticles.
Qiu L; Zhang Y; Wei G; Wang C; Zhu Y; Yang T; Chu Z; Gao P; Cheng G; Ma A; Kwan Wong Y; Zhang J; Xu C; Wang J; Tang H
J Colloid Interface Sci; 2023 Oct; 648():497-510. PubMed ID: 37307606
[TBL] [Abstract][Full Text] [Related]
8. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
9. Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.
Zhao T; Ren M; Shi J; Wang H; Bai J; Du W; Xiang B
Biomed Pharmacother; 2024 Jun; 175():116627. PubMed ID: 38653112
[TBL] [Abstract][Full Text] [Related]
10. Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System.
Srivastav AK; Dhiman N; Khan H; Srivastav AK; Yadav SK; Prakash J; Arjaria N; Singh D; Yadav S; Patnaik S; Kumar M
J Pharm Sci; 2019 May; 108(5):1872-1889. PubMed ID: 30615879
[TBL] [Abstract][Full Text] [Related]
11. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake.
Di Silvio D; Rigby N; Bajka B; Mackie A; Baldelli Bombelli F
Int J Biochem Cell Biol; 2016 Jun; 75():212-22. PubMed ID: 26520468
[TBL] [Abstract][Full Text] [Related]
12. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
Xiao W; Gao H
Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
[TBL] [Abstract][Full Text] [Related]
13. The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis.
Wang X; Zhang W
J Control Release; 2022 May; 345():832-850. PubMed ID: 35367478
[TBL] [Abstract][Full Text] [Related]
14. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
15. The protein corona and its effects on nanoparticle-based drug delivery systems.
Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
[TBL] [Abstract][Full Text] [Related]
16. Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment.
Bonvin D; Aschauer U; Alexander DTL; Chiappe D; Moniatte M; Hofmann H; Mionić Ebersold M
Small; 2017 Aug; 13(29):. PubMed ID: 28582610
[TBL] [Abstract][Full Text] [Related]
17. Combinatory interpretation of protein corona and shear stress for active cancer targeting of bioorthogonally clickable gelatin-oleic nanoparticles.
Meghani NM; Amin H; Park C; Cui JH; Cao QR; Choi KH; Lee BJ
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110760. PubMed ID: 32279783
[TBL] [Abstract][Full Text] [Related]
18. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
19. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.
Ding T; Sun J
Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347
[TBL] [Abstract][Full Text] [Related]
20. Protein corona and nanoparticles: how can we investigate on?
Pederzoli F; Tosi G; Vandelli MA; Belletti D; Forni F; Ruozi B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28296346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
